Voyager Therapeutics (VYGR) EBIT Margin Growth (5y) (2020 - 2026)
Powered by 
Analysis
Voyager Therapeutics (VYGR) EBIT Margin Growth (5y) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 10.60 Bn | 9.76 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.39 Bn | 5.39 Bn | - |
| 3 | Iovance Biotherapeutics | 3.98 Bn | 3.68 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.97 Bn | 3.00 Bn | 251.50 Mn |
| 5 | uniQure | 3.09 Bn | 3.09 Bn | 5.49 Mn |
| 6 | Beam Therapeutics | 3.06 Bn | 3.06 Bn | - |
| 7 | Precigen | 2.54 Bn | 2.54 Bn | 52.17 Mn |
| 8 | Sarepta Therapeutics | 2.38 Bn | 1.58 Bn | 251.87 Mn |
| 9 | Vericel | 2.06 Bn | 1.89 Bn | 56.40 Mn |
| 10 | Voyager Therapeutics | 215.07 Mn | 98.73 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 128,173.00 |
| Mar 31, 2026 | -77,061.00 |
| Dec 31, 2025 | 16,782.00 |
| Sep 30, 2025 | -30,004.00 |
| Jun 30, 2025 | -67,301.00 |
| Mar 31, 2025 | -39,850.00 |
| Dec 31, 2024 | -56,791.00 |
| Sep 30, 2024 | 3,120.00 |
| Jun 30, 2024 | -7,070.00 |
| Mar 31, 2024 | 48,073.00 |
| Dec 31, 2023 | 121,347.00 |
| Sep 30, 2023 | 37,038.00 |
| Jun 30, 2023 | 47,893.00 |
| Mar 31, 2023 | 232,083.00 |
| Dec 31, 2022 | 177,927.00 |
| Sep 30, 2022 | 206,956.00 |
| Jun 30, 2022 | -113,648.00 |
| Mar 31, 2022 | -204,782.00 |
| Dec 31, 2021 | 60,638.00 |
| Sep 30, 2021 | -138,325.00 |